About Arcutis Biotherapeutics, Inc.

Arcutis Biotherapeutics, Inc. engages in the development and commercialization of treatments for dermatological diseases. Its piepline consists of topical treatments for plaque psoriasis, atopic dermatitis, eczema, vitiligo, alopecia areata, and seborrheic dermatitis. The company was founded by Bhaskar Chaudhuri and David W. Osborne on June 1, 2016 and is headquartered in Westlake Village, CA.

At the moment the company doesn't generate any revenue.

On its last earning announcement, the company reported a loss of -1.97$ per share.

The book value per share is -1.45$

Arcutis Biotherapeutics, Inc. website

Create a solid portfolio with ARQT

Add ARQT to your portfolio and optimize it!


Financials

Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
- - -36M - -35M -1.97 - - 18M -1.45 -32M - -32M